Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A45625 | 23582593 | Curr Probl Pediatr Adolesc Health Care | Metabolic syndrome in pediatrics: old concepts revised, new concepts discussed. | 2013 | Details |
| A45646 | 23475416 | Endocr Rev | Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. | 2013 | Details |
| A45648 | 23471889 | Diabetes Metab Res Rev | Hepatic manifestations of metabolic syndrome. | 2013 | Details |
| A45649 | 23467323 | Am J Physiol Regul Integr Comp Physiol | Hepatic steatosis development with four weeks of physical inactivity in previously active, hyperphagic OLETF rats. | 2013 | Details |
| A45651 | 23448486 | Curr Pharm Des | Role of adiponectin in the metabolic syndrome: current perspectives on its modulation as a treatment strategy. | 2013 | Details |
| A45657 | 23423574 | Diabetes | Targeting pyruvate carboxylase reduces gluconeogenesis and adiposity and improves insulin resistance. | 2013 | Details |
| A45679 | 23304111 | PPAR Res | Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity. | 2012 | Details |
| A45681 | 23298629 | J Hepatol | Drug-induced liver injury in obesity. | 2013 | Details |
| A45684 | 23295629 | Food Chem Toxicol | Protective effects of matrine against progression of high-fructose diet-induced steatohepatitis by enhancing antioxidant and anti-inflammatory defences involving Nrf2 translocation. | 2013 | Details |
| A45693 | 23259217 | Lakartidningen | [Non-alcoholic fatty liver disease can cause permanent liver damage]. | 2013 | Details |
| A45707 | 23175050 | Hepatology | Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats. | 2013 | Details |
| A45710 | 23156704 | J Zoo Wildl Med | Hemochromatosis and fatty liver disease: building evidence for insulin resistance in bottlenose dolphins (Tursiops truncatus). | 2012 | Details |
| A45723 | 23070526 | Sleep Breath | Obstructive sleep apnea and dyslipidemia: importance of the liver axis. | 2012 | Details |
| A45724 | 23069475 | J Hepatol | From lung to liver: how does airborne particulate matter trigger NASH and systemic insulin resistance? | 2012 | Details |
| A45762 | 22882641 | Diabet Med | Fatty liver: cause or consequence. | 2012 | Details |
| A45763 | 22877991 | Biochim Biophys Acta | Physiological roles of phosphatidylethanolamine N-methyltransferase. | 2012 | Details |
| A45768 | 22858195 | Nutrition | Nonalcoholic fatty liver disease as a pro-resolution defective disorder. | 2012 | Details |
| A45775 | 22813567 | Diabetes Metab Syndr | Insulin resistance and alanine amino transaminase (ALT) levels in first degree relatives of type 2 diabetes mellitus. | 2012 | Details |
| A45779 | 22801247 | J Investig Med | Effect of insulin versus triple oral therapy on the progression of hepatic steatosis in type 2 diabetes. | 2012 | Details |
| A45781 | 22792473 | Int J Hepatol | Etiopathogenesis of nonalcoholic steatohepatitis: role of obesity, insulin resistance and mechanisms of hepatotoxicity. | 2012 | Details |
| A45792 | 22715101 | J Biol Chem | The ABCG5 ABCG8 sterol transporter opposes the development of fatty liver disease and loss of glycemic control independently of phytosterol accumulation. | 2012 | Details |
| A45796 | 22696577 | Am J Physiol Regul Integr Comp Physiol | Potential clinical translation of juvenile rodent inactivity models to study the onset of childhood obesity. | 2012 | Details |
| A45804 | 22652784 | Front Biosci (Landmark Ed) | Obesity-related hepatocellular carcinoma: roles of risk factors altered in obesity. | 2012 | Details |
| A45817 | 22560205 | Cell Metab | Cell Metabolism 2012 focus on lipids and insulin resistance. | 2012 | Details |
| A45818 | 22553843 | Zhonghua Gan Zang Bing Za Zhi | [Study on dysmetabolism in patients with non-alcoholic fatty liver disease and its different combinations]. | 2011 | Details |
| A45822 | 22527892 | Endocrine | Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin. | 2012 | Details |
| A45836 | 23798298 | Compr Physiol | Lack of exercise is a major cause of chronic diseases. | 2012 | Details |
| A45845 | 22425588 | Gastroenterology | Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. | 2012 | Details |
| A45853 | 22383493 | Am J Physiol Gastrointest Liver Physiol | When GLP-1 hits the liver: a novel approach for insulin resistance and NASH. | 2012 | Details |
| A45855 | 22371327 | Hepatology | Diagnostic accuracy of adipose insulin resistance index and visceral adiposity index for progressive liver histology and cardiovascular risk in nonalcoholic fatty liver disease. | 2012 | Details |
| A45881 | 22219592 | World J Gastroenterol | Impact of liver diseases on the development of type 2 diabetes mellitus. | 2011 | Details |
| A45885 | 22209682 | J Nutr Biochem | Oleic acid activates peroxisome proliferator-activated receptor δ to compensate insulin resistance in steatotic cells. | 2011 | Details |
| A45894 | 22166577 | Ann Hepatol | Hormone replacement therapy in menopausal women: risk factor or protection to nonalcoholic fatty liver disease? | 2012 | Details |
| A45897 | 22154323 | Metabolism | Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice. | 2011 | Details |
| A45902 | 22152375 | Zhonghua Gan Zang Bing Za Zhi | [Pancreatic derived factor (PANDER) and non-alcoholic fatty liver disease (NAFLD)]. | 2011 | Details |
| A45909 | 22130312 | Clin Chim Acta | Thyroid function in childhood obesity and metabolic comorbidity. | 2011 | Details |
| A45917 | 22093451 | Liver Int | Understanding the relationship between PNPLA3, NAFLD and insulin resistance: do ethnic differences bring more questions or more answers? | 2011 | Details |
| A45929 | 22005190 | Adv Cardiol | Metabolic disorders associated with obstructive sleep apnea in adults. | 2011 | Details |
| A45947 | 21904679 | Biochem Res Int | The increased activity of liver lysosomal lipase in nonalcoholic Fatty liver disease contributes to the development of hepatic insulin resistance. | 2011 | Details |
| A45950 | 21898494 | Hepatology | Where are we in the search for noninvasive nonalcoholic steatohepatitis biomarkers? | 2011 | Details |
| A45966 | 21805747 | Zhonghua Gan Zang Bing Za Zhi | [The relationship between nonalcoholic fatty liver disease and polycystic ovarian syndrome]. | 2011 | Details |
| A45968 | 21788578 | Diabetes | The metabolically benign and malignant fatty liver. | 2011 | Details |
| A45972 | 21770296 | Nihon Naika Gakkai Zasshi | [The cutting-edge of medicine; clinical and molecular pathology of type 2 diabetic liver]. | 2011 | Details |
| A45988 | 21713308 | Cardiovasc J Afr | Serving diabetes and cardiology: round three of the South African diabetologist/cardiologist debate. | 2011 | Details |
| A45994 | 21701901 | Hepatol Int | Murine gamma herpes virus 68 infection promotes fatty liver formation and hepatic insulin resistance in C57BL/6J mice. | 2011 | Details |
| A45996 | 21697185 | Alcohol Alcohol | Alcoholic and non-alcoholic fatty liver in adolescents: a worrisome convergence. | 2011 | Details |
| A46011 | 21564446 | Int J Clin Pract | Rimonabant improves cholesterol, insulin resistance and markers of non-alcoholic fatty liver in morbidly obese patients: a retrospective cohort study. | 2011 | Details |
| A46017 | 21536711 | Endocr Rev | Genetic syndromes of severe insulin resistance. | 2011 | Details |
| A46021 | 21520192 | Hepatology | Insulin resistance links nonalcoholic fatty liver to cardiovascular diseases. | 2011 | Details |
| A46028 | 21488942 | J Gastroenterol Hepatol | SREBP-2: a link between insulin resistance, hepatic cholesterol, and inflammation in NASH. | 2011 | Details |
| A46031 | 21480350 | Hepatology | Insulin sensitizers in nonalcoholic steatohepatitis. | 2011 | Details |
| A46032 | 21476910 | Expert Rev Gastroenterol Hepatol | Relevance of TNF-α gene polymorphisms in nonalcoholic fatty liver disease. | 2011 | Details |
| A46040 | 21454445 | Am J Physiol Gastrointest Liver Physiol | Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet. | 2011 | Details |
| A46043 | 21441697 | Circ J | Prevention of atherosclerosis in overweight/obese patients. - In need of novel multi-targeted approaches-. | 2011 | Details |
| A46045 | 21435084 | Helicobacter | The association between Helicobacter pylori infection and insulin resistance: a systematic review. | 2011 | Details |
| A46059 | 21366813 | Pediatr Diabetes | Use of metformin in pediatric age. | 2011 | Details |
| A46065 | 21332536 | J Gastroenterol Hepatol | Should all patients with nonalcoholic fatty liver disease undergo oral glucose tolerance test? | 2011 | Details |
| A46068 | 21300117 | J Hepatol | Effect of treatment with polyunsaturated fatty acids on HCV- or diet-induced fatty liver. | 2011 | Details |
| A46085 | 21194387 | Antioxid Redox Signal | Adipokines and redox signaling: impact on fatty liver disease. | 2011 | Details |
| A46087 | 21167426 | Ann Pathol | [Non-alcoholic fatty liver disease]. | 2010 | Details |
| A46094 | 21142633 | Future Cardiol | Sugar-sweetened beverages and hypertension. | 2010 | Details |
| A46099 | 21105450 | Vnitr Lek | [Complications of obesity--pathogenesis]. | 2010 | Details |
| A46100 | 21105109 | Hepatology | Therapeutic trials in nonalcoholic steatohepatitis: insulin sensitizers and related methodological issues. | 2010 | Details |
| A46117 | 20967760 | Hepatology | Disruption of the 12/15-lipoxygenase gene (Alox15) protects hyperlipidemic mice from nonalcoholic fatty liver disease. | 2010 | Details |
| A46119 | 20962018 | J Clin Endocrinol Metab | The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index. | 2010 | Details |
| A46125 | 20880166 | J Gastroenterol Hepatol | Failure of islet β-cell compensation for insulin resistance causes type 2 diabetes: what causes non-alcoholic fatty liver disease and non-alcoholic steatohepatitis? | 2010 | Details |
| A46126 | 20879883 | N Engl J Med | Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A46134 | 20822767 | Am J Obstet Gynecol | Maternal high-fat intake predisposes nonalcoholic fatty liver disease in C57BL/6 offspring. | 2010 | Details |
| A46139 | 20807839 | Am J Physiol Endocrinol Metab | A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain. | 2010 | Details |
| A46141 | 20799351 | Hepatology | Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity. | 2010 | Details |
| A46142 | 20798858 | J Obes | Long-term effects of metformin and lifestyle modification on nonalcoholic Fatty liver disease obese adolescents. | 2010 | Details |
| A46147 | 20724529 | Am J Physiol Gastrointest Liver Physiol | Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine. | 2010 | Details |
| A46149 | 20717042 | J Clin Gastroenterol | The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literature. | 2011 | Details |
| A46150 | 20714438 | Int J Med Sci | Predictors of hepatic steatosis in HBeAg-negative chronic hepatitis B patients and their diagnostic values in hepatic fibrosis. | 2010 | Details |
| A46151 | 20710138 | South Med J | Nonalcoholic steatohepatitis: a review of the literature and updates in management. | 2010 | Details |
| A46160 | 20653078 | N Engl J Med | Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. | 2010 | Details |
| A46161 | 20653077 | N Engl J Med | Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. | 2010 | Details |
| A46163 | 20648554 | Hepatology | Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease. | 2010 | Details |
| A46167 | 20633523 | J Acupunct Meridian Stud | Effects of Teucrium polium on Insulin Resistance in Nonalcoholic Steatohepatitis. | 2010 | Details |
| A46174 | 20581678 | Curr Opin Lipidol | Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance. | 2010 | Details |
| A46177 | 20566726 | CMAJ | Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. | 2010 | Details |
| A46184 | 20490434 | Braz J Med Biol Res | Beneficial effects of exercise training (treadmill) on insulin resistance and nonalcoholic fatty liver disease in high-fat fed C57BL/6 mice. | 2010 | Details |
| A46189 | 20458758 | World J Gastroenterol | Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease. | 2010 | Details |
| A46191 | 20454765 | ScientificWorldJournal | Resolution of adipose tissue inflammation. | 2010 | Details |
| A46196 | 20423314 | Curr Med Chem | Pathophysiological role of pigment epithelium-derived factor (PEDF) in hepatic disorders. | 2010 | Details |
| A46198 | 20415823 | Dermatol Ther | Psoriasis, the liver, and the gastrointestinal tract. | 2010 | Details |
| A46202 | 20391295 | Semin Thromb Hemost | Disorders of coagulation and hemostasis in abdominal obesity: emerging role of fatty liver. | 2010 | Details |
| A46203 | 20385430 | J Hepatol | Combination of acarbose and ezetimibe prevents non-alcoholic fatty liver disease: a break of intestinal insulin resistance? | 2010 | Details |
| A46205 | 20375212 | J Clin Endocrinol Metab | Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. | 2010 | Details |
| A46209 | 20371660 | J Clin Endocrinol Metab | Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease. | 2010 | Details |
| A46212 | 20347746 | J Am Coll Surg | Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation. | 2010 | Details |
| A46213 | 20335584 | N Engl J Med | Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. | 2010 | Details |
| A46214 | 20304711 | Dig Liver Dis | Introduction to the Mini-Symposium on non-alcoholic fatty liver disease. | 2010 | Details |
| A46218 | 20222092 | Hepatology | Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. | 2010 | Details |
| A46219 | 20217240 | Mol Biol Rep | Oxidative stress induced by high-glucose diet in liver of C57BL/6J mice and its underlying mechanism. | 2010 | Details |
| A46221 | 20211973 | Endocrinology | Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet. | 2010 | Details |
| A46223 | 20207831 | Endocrinology | A maternal "junk food" diet in pregnancy and lactation promotes nonalcoholic Fatty liver disease in rat offspring. | 2010 | Details |
| A46224 | 20207207 | Dig Liver Dis | Prevention and treatment of nonalcoholic fatty liver disease. | 2010 | Details |
| A46225 | 20197789 | Eur J Clin Nutr | Berry meals and risk factors associated with metabolic syndrome. | 2010 | Details |
| A46226 | 30764047 | Expert Rev Endocrinol Metab | Hepatitis C and metabolic syndrome. | 2010 | Details |